What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
Studies have examined BPC-157 in models of gastric lesions, intestinal anastomosis, and inflammatory bowel conditions in animal subjects (Sikiric et al., Journal of Physiology-Paris, 2003)
The room temperature stability data can help you estimate safe transit times
10.1016/j.biomaterials.2007.12.037 45 De SimoneU.RoccioM.GribaldoL.SpinilloA.CaloniF.CocciniT
THE STABILIZER: PEMF (Pulsed Electromagnetic Fields) The Concept: The System Reset